Skip to main content
Top
Literature
1.
go back to reference Saadeh SA, Baracco R, Jain A, Kapur G, Mattoo TK, Valentini RP (2011) Weight or body surface area dosing of steroids in nephrotic syndrome: is there an outcome difference? Pediatr Nephrol 26:2167–2171PubMedCrossRef Saadeh SA, Baracco R, Jain A, Kapur G, Mattoo TK, Valentini RP (2011) Weight or body surface area dosing of steroids in nephrotic syndrome: is there an outcome difference? Pediatr Nephrol 26:2167–2171PubMedCrossRef
2.
go back to reference Mehls O, Hoyer PF (2011) Dosing of glucocorticosteroids in nephrotic syndrome. Pediatr Nephrol 26:2095–2098PubMedCrossRef Mehls O, Hoyer PF (2011) Dosing of glucocorticosteroids in nephrotic syndrome. Pediatr Nephrol 26:2095–2098PubMedCrossRef
3.
go back to reference Frey BM, Walker C, Frey FJ, De Weck AL (1984) Pharmacokinetics and pharmacodynamics of three different prednisolone prodrugs: effect on circulating lymphocyte subsets and function. J Immunol 133:2479–2487PubMed Frey BM, Walker C, Frey FJ, De Weck AL (1984) Pharmacokinetics and pharmacodynamics of three different prednisolone prodrugs: effect on circulating lymphocyte subsets and function. J Immunol 133:2479–2487PubMed
Metadata
Title
Weight dosing of steroids in nephrotic syndrome
Authors
Thomas J. Neuhaus
Guido F. Laube
Publication date
01-03-2012
Publisher
Springer-Verlag
Published in
Pediatric Nephrology / Issue 3/2012
Print ISSN: 0931-041X
Electronic ISSN: 1432-198X
DOI
https://doi.org/10.1007/s00467-011-2091-7

Other articles of this Issue 3/2012

Pediatric Nephrology 3/2012 Go to the issue